end-stage congenital dysplasia of the hip
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years, gender is not limited; 2. Total hip replacement due to end-stage DDH disease; 3. The American Society of Anesthesiologists (ASA) grades are I-III; 4. Patients with or without controlled blood pressure during the perioperative period; 5. Patients undergoing general anesthesia surgery.
Exclusion criteria
Exclusion criteria: 1. Combined with severe cerebrovascular accident and neurological disease; 2. Complined with severe cardiovascular disease and liver and kidney insufficiency; 3. Combined with severe anemia, hypovolemia and coagulation dysfunction; 4. Complined with resistant hypertension and peripheral vascular disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total perioperative blood loss;Dominant blood loss;Hidden blood loss;Transfusion rate;Transfusion volume; | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of surgery/anesthesia;Complications;Postoperative liver and kidney function;Incidence of acute myocardial injury;Incidence of acute kidney injury;Incidence of postoperative hypotension; | — |
Countries
China
Contacts
West China Hospital, Sichuan University